Alternatives to Mabylon
Mabylon is a Biotech tool: mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Mabylon
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
TippingPoint Biosciences59BiotechCambridge, USA$14.5MDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
- Website
Adimab53BiotechLebanon, United States$105.0MAdimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.
- Website
Tharimmune53BiotechCambridge, United States$540.0MBiotechnology company developing novel immunotherapies for cancer.
- Website
MacroGenics49BiotechRockville, United States$13.5MBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
- Website
Adicet Bio48BiotechBoston, United States$389.0MClinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
- Website
Dren Bio48BiotechSan Carlos, United States$156.0MBiopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.
- Website LELeman Biotech48BiotechShenzhen, China$22.7M
Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
32 Biosciences42BiotechSan Diego, United States$12.0MDevelops novel therapeutic antibodies for oncology and autoimmune diseases.
- Website
Purple Biotech20BiotechTel Aviv, IsraelClinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
ImCheck Therapeutics60BiotechMarseille, France$164.0MImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Relay Therapeutics58BiotechCambridge, United States$825.0MClinical-stage precision medicine company using protein motion insights for drug discovery.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
ProteinQure54BiotechCambridge, United States$15.6MBiotech company using AI and computational platforms to design novel peptide therapeutics.
Showing the 20 closest matches. See the rest on the Mabylon profile.
Compare Mabylon head to head
Side by side on what each one does, what it costs, and what real users report.